Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival (Q42244116)

From Wikidata
Jump to navigation Jump to search
scientific article published on January 1994
edit
Language Label Description Also known as
English
Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival
scientific article published on January 1994

    Statements

    Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit